There is no single test called a gut health test in clinical medicine. A doctor works through a short list of named assays, each answering one narrow question, and picks based on what your symptoms look like. The history decides the test, not the other way round.
Three separate industries sell things under the gut health banner, and they answer different questions. Most people searching for how doctors test gut health want the third tier: the conventional clinical workup. This page covers what a physician orders, what symptom pattern triggers each test, what a positive result changes, and who pays.
The Verdict
Three tiers of gut testing, and which one you want
The three tiers differ in who orders the test, what regulatory footing it stands on, and what a result is allowed to conclude. Listed alphabetically by tier.
| Tier | What it answers | Who orders it | Regulatory footing | What it will not do |
|---|---|---|---|---|
| Consumer microbiome kits | Which microbes appear in one stool sample, plus a model-generated food or supplement list | You, direct to consumer | Sold as wellness products. Not regulated as diagnostic devices. | Diagnose anything, or rule anything out |
| Conventional clinical testing | Is there inflammation, infection, bleeding, malabsorption or structural disease | Primary care first, gastroenterology on referral | Validated assays with published cut-offs and guideline-defined indications | Tell you which specific foods suit you |
| Functional-medicine panels | A broad profile of stool organisms plus digestive and permeability markers | Naturopaths, functional and integrative practitioners, some physicians | Run in CLIA-certified labs as laboratory-developed tests. Most are not FDA-cleared. | Replace the workup a red-flag symptom needs |
The consumer tier is the one most people meet first, through brands like Viome and Zoe. Those products sequence a stool sample properly, then build a proprietary score and food list on top of it, and the score is a model rather than a clinical standard. Our page on whether gut health tests are accurate covers that layer in full, and best gut health test covers buying one. The rest of this page stays in the clinical lane.
The tests a gastroenterologist actually orders
Seven test groups cover almost every first-line gut investigation. They are listed alphabetically below, not in order of importance, because the order you meet them in depends entirely on your symptoms.
Blood tests: full blood count, ferritin and CRP
Basic blood work is the first-line screen, and it is ordered before any stool or breath test. A full blood count picks up anemia and raised platelets. Ferritin identifies iron deficiency, which is often the first sign of slow blood loss from the gut. CRP flags systemic inflammation.
The trigger is any persistent gut symptom at all. What a positive result changes is the urgency: iron-deficiency anemia in a man, or in a woman past menopause, with no obvious cause is an indication for endoscopic investigation rather than a trial of diet change. Our page on hs-CRP explains what the inflammation marker does and does not capture.
Celiac serology: tissue transglutaminase IgA
Celiac serology is a blood test for the antibodies produced when someone with celiac disease eats gluten. The first-line assay is tissue transglutaminase IgA, and it is ordered alongside a total IgA level because roughly one in forty people with celiac disease is IgA deficient, which makes the main test read falsely negative.
The trigger is diarrhea, bloating, unexplained iron deficiency, weight loss, or a first-degree relative with celiac disease. A positive result usually leads to an upper endoscopy with duodenal biopsies to confirm, and then to a permanent gluten-free diet.
Colonoscopy
Colonoscopy is the only test on this list that looks directly at the bowel lining and takes tissue. A camera examines the full colon, polyps are removed during the same procedure, and biopsies are taken from areas that look abnormal or, in suspected microscopic colitis, from areas that look normal.
Two things trigger it. The first is screening: US guidance from the US Preventive Services Task Force now starts average-risk colorectal cancer screening at age 45. The second is a red-flag symptom at any age. What a positive result changes is everything downstream, because colonoscopy is the test that confirms inflammatory bowel disease, finds cancers and precancerous polyps, and settles questions the stool markers can only point at.
Fecal calprotectin
Fecal calprotectin, spelled faecal calprotectin in the UK, is the most useful single triage test in this whole list. Calprotectin is a protein released by neutrophils, the white cells that migrate into the bowel wall when the mucosa is inflamed. Measuring it in stool tells you whether there is genuine intestinal inflammation.
That answers the question that changes everything else: is this inflammatory bowel disease or is this irritable bowel syndrome. The two produce overlapping symptoms and completely different treatment paths. Most labs use a cut-off around 50 micrograms per gram, with some reporting an intermediate band up to 100 or 150. NICE recommends it in the UK specifically to distinguish inflammatory bowel disease from IBS in adults with lower gut symptoms where cancer is not suspected. A clearly raised result routes you to colonoscopy. A low result in a young patient with typical IBS symptoms and no red flags makes inflammatory disease unlikely and spares an invasive test.
Helicobacter pylori: urea breath test and stool antigen
H. pylori is a bacterium that colonizes the stomach lining and causes ulcers, gastritis, and a raised risk of gastric cancer. Two tests find active infection: the urea breath test, which detects labelled carbon dioxide released when the organism breaks down a swallowed urea drink, and the stool antigen test, which detects bacterial protein in stool. Both indicate current infection.
The trigger is upper abdominal pain, dyspepsia, reflux that has not responded to treatment, or a history of peptic ulcer. A positive result means a course of eradication therapy, typically several antibiotics with acid suppression, followed by a repeat test to confirm the infection has cleared.
The failure mode here is drug interference, and it is common. Proton pump inhibitors suppress the organism without eradicating it, which produces a false negative on both the breath test and the stool antigen test. Standard practice is to stop the PPI around two weeks before testing, and to be at least four weeks clear of antibiotics or bismuth. Blood antibody testing avoids that problem but creates a worse one: antibodies persist for years after successful treatment, so a positive serology cannot tell a current infection from one cleared a decade ago.
Hydrogen and methane breath testing for SIBO
Breath testing for small intestinal bacterial overgrowth measures the gases bacteria produce after you drink a sugar solution. You swallow lactulose or glucose, then give timed breath samples while the analyzer tracks hydrogen and methane. The commonly used consensus criteria call a rise of 20 parts per million or more in hydrogen above baseline within 90 minutes positive for bacterial overgrowth, and a methane level of 10 parts per million or more at any point positive for intestinal methanogen overgrowth.
The trigger is bloating that starts 30 to 90 minutes after eating, abdominal distension that worsens through the day, and diarrhea or constipation that has not responded to standard IBS management. A positive result usually leads to a course of antibiotics, most often rifaximin.
The validity of this test is genuinely contested, and you should know that before paying for one. The core problem is that lactulose speeds up transit through the small bowel, so an early gas rise may simply mean the sugar reached the colon faster than usual rather than that bacteria are in the wrong place. Guidance from the American College of Gastroenterology acknowledges the limits of breath testing while still supporting its use in selected patients, and aspiration and culture of small-bowel fluid, the reference standard, is invasive and rarely done. The practical position: a positive breath test supports a treatment trial, and it is not the same grade of evidence as a raised calprotectin.
Stool culture, PCR panels and parasite testing
Stool testing for infection now runs mostly on multiplex PCR panels that detect the nucleic acid of twenty or more bacteria, viruses and parasites from one sample in a few hours. Traditional culture still has a role for antibiotic susceptibility. Ova and parasite microscopy is the older method for parasites and typically needs samples collected on different days, since shedding is intermittent, while antigen and PCR tests for Giardia and Cryptosporidium detect them from a single sample.
The trigger is acute or persistent diarrhea, especially after foreign travel, after antibiotics, after a suspect meal, or with fever and blood. A positive result identifies the organism and decides whether you need targeted treatment or simply supportive care while it clears.
One non-obvious catch applies to Clostridioides difficile. PCR detects the gene for the toxin, not the toxin itself, so it can flag someone who carries the organism without disease. That is why many labs run a two-step algorithm, screening with an antigen or PCR test and confirming with a toxin immunoassay. If your PCR is positive but the toxin assay is negative and you have no diarrhea, you are more likely a carrier than a patient. Treating that person with antibiotics is a real harm, not a theoretical one.
Red-flag symptoms change the pathway
Certain symptoms move you from a stepwise workup to a prompt referral, because they raise the probability of cancer, inflammatory bowel disease, or bleeding. They are not more severe versions of ordinary symptoms; they are different signals.
What changes with a red flag is sequencing and speed. Instead of trying a diet change and reviewing in six weeks, a clinician orders blood work and stool markers straight away and refers for endoscopic assessment. Buying a mail-order test while a red flag is present costs weeks, and those weeks are the part that matters.
The functional-medicine tier: GI-MAP and zonulin
Functional-medicine stool panels are real laboratory tests whose interpretive frameworks sit outside mainstream gastroenterology guidance. A widely used example is GI-MAP, from Diagnostic Solutions Laboratory, a quantitative PCR panel run on one stool sample. GI Effects, from Genova Diagnostics, is a comparable panel using a mix of methods. Both run in labs certified under CLIA, the federal standard for clinical laboratory quality.
It is worth separating two things these panels report. Some analytes are mainstream: calprotectin, pancreatic elastase, occult blood and recognized pathogens are the same markers a gastroenterologist uses. Others are the panel's own construct, including quantitative reference ranges for commensal and opportunistic bacteria and the dysbiosis scores built from them. Those reference ranges are proprietary. Gastroenterology societies do not currently define a normal stool microbiome or recommend treating a bacterial abundance result, because no such standard exists.
CLIA certification is a quality standard for how a laboratory runs, not evidence that a given result predicts anything. Most functional panels are laboratory-developed tests, which historically have not required FDA clearance to be offered.
Zonulin is the marker worth understanding separately, because it carries the intestinal permeability claim. Zonulin is a protein proposed to regulate the tight junctions between intestinal cells, and commercial panels sell blood or stool zonulin as a leaky gut measure. Independent analyses have reported that widely used commercial zonulin ELISA kits detect proteins other than zonulin itself, so the analytical validity is in question before interpretation begins. Separately, no zonulin cut-off has an established management decision attached to it. Increased intestinal permeability is a real phenomenon documented in celiac disease and inflammatory bowel disease; the consumer test marketed to measure it is not part of any diagnostic pathway.
Who orders what, and who pays
Primary care orders the first tier and gastroenterology owns the rest. A GP or family physician can order blood work, celiac serology, fecal calprotectin, H. pylori testing and stool pathogen panels without referring you anywhere. Gastroenterology is where endoscopy, breath testing and complex cases go. Samples for most of these run at large reference labs, including Labcorp and Quest Diagnostics, or at the hospital lab.
In the US, coverage turns on whether a test is diagnostic or screening. Diagnostic means it investigates a documented symptom or abnormal result, and that is typically covered subject to your deductible and coinsurance. Preventive colorectal cancer screening is covered without cost-sharing on most plans. The trap sits between the two: a colonoscopy booked as screening can be re-coded as diagnostic if a polyp is removed, which changes what you owe. Ask how the procedure will be billed if something is found, before the day.
Medicare Part B covers medically necessary clinical diagnostic laboratory tests ordered by a treating clinician, and beneficiaries generally pay nothing for the lab test itself. Medically indicated stool testing therefore qualifies; a wellness microbiome profile does not. Medicare also covers colorectal cancer screening, and since 2023 a follow-up colonoscopy after a positive stool-based screening test is treated as part of the screening rather than as a new diagnostic procedure.
UK readers follow one route: a GP orders blood work, celiac serology, faecal calprotectin and FIT, and refers to hospital gastroenterology on NHS pathways if a marker is raised or a red flag is present.
Approximate costs if you are paying yourself
The figures below are approximate US self-pay bands and vary widely by lab, region and plan. Listed alphabetically by test.
| Test | Approximate US self-pay cost | Usually covered when diagnostic? |
|---|---|---|
| Blood panel (full blood count, ferritin, CRP) | $30–$100 | Yes, with a documented symptom or finding |
| Celiac serology (tTG-IgA with total IgA) | $50–$150 | Yes, with a documented symptom or finding |
| Colonoscopy | $1,000–$3,000 or more | Yes, but cost-sharing differs between screening and diagnostic |
| Fecal calprotectin | $50–$200 | Usually, with documented lower-GI symptoms |
| GI-MAP and similar functional stool panels | $350–$600 | Rarely |
| H. pylori breath or stool antigen test | $50–$200 | Yes, with dyspepsia or ulcer history documented |
| Hydrogen and methane breath test (SIBO) | $150–$350 | Variable. Some plans decline it. |
| Stool culture with multiplex PCR panel | $100–$500 | Yes, with documented acute or persistent diarrhea |
Which tier do your symptoms belong in?
Match the tier to the question you actually have, and the decision becomes simple. Three rules cover nearly everyone.
Any red flag goes to a physician, immediately. Bleeding, unintentional weight loss, anemia, symptoms waking you at night, a bowel-habit change after 50, or a close family history. No mail-order test contributes anything at this point, and the delay is the cost.
A specific, persistent symptom goes to the clinical tier. Diarrhea or abdominal pain lasting weeks, reflux or upper-gut pain, bloating with distension, or symptoms after travel or antibiotics. Each maps to a named test above, and the tests are cheap, validated and usually covered. Buying a sequencing kit for these questions is buying an answer to a different question.
Curiosity, baseline and food personalization go to the consumer tier. If you have no red flags, no persistent symptom, and you want to see what a stool profile looks like before changing your diet, a consumer kit is a reasonable purchase as long as you read the score as a model rather than a diagnosis. If you want a clinician to look at all of it with you, our doctor-led options page compares the programs that combine testing with physician review.
Frequently Asked Questions
What is a gut health test called?
There is no single test with that name in clinical medicine. Doctors order named assays that each answer one question: fecal calprotectin for intestinal inflammation, tissue transglutaminase IgA for celiac disease, a urea breath test or stool antigen test for Helicobacter pylori, a stool culture with a multiplex PCR panel for pathogens and parasites, a hydrogen and methane breath test for small intestinal bacterial overgrowth, and colonoscopy for direct visual assessment and biopsy. The phrase "gut health test" belongs to the consumer market, where it usually means a stool sequencing kit. If you ask a physician for a gut health test, they will ask what symptom you are trying to explain, then pick from the list above.
How do doctors check gut health at a first appointment?
They take a history and order blood work, and the history does most of the work. A doctor is sorting your symptoms into a few buckets: inflammatory, infectious, malabsorptive, structural, or functional. The first-line tests are cheap and fast: a full blood count for anemia and raised platelets, ferritin for iron deficiency, CRP for systemic inflammation, and celiac serology. Fecal calprotectin is often added when the main complaint is diarrhea or abdominal pain. Those results decide whether you need a gastroenterology referral or a trial of treatment.
Can I get a gut health test at Labcorp or Quest?
Yes for the clinical assays, and most of them need an order from a clinician. Labcorp and Quest Diagnostics both run celiac serology, fecal calprotectin, H. pylori stool antigen, stool culture and PCR pathogen panels, and the routine blood work that precedes them. Both also operate consumer-pay arms that let you buy a limited menu without a physician order, though availability varies by state. What neither offers is a consumer microbiome sequencing report of the kind sold by direct-to-consumer brands, because that is not a clinical assay.
Does insurance cover a gut health test?
Insurance generally covers testing that is diagnostic, meaning it is ordered to investigate a documented symptom or abnormal finding. It generally does not cover testing bought out of curiosity. That distinction is why the same colonoscopy can be free at the point of use as preventive screening and carry cost-sharing when it is performed to investigate rectal bleeding. Functional-medicine stool panels are usually paid out of pocket. If coverage matters to you, the practical step is to get the symptom written into the chart before the test is ordered, not after.
Does Medicare cover stool testing?
Yes, when the test is medically necessary and ordered by a treating clinician, and there is generally no coinsurance for the lab test itself under Part B. The word doing the work is necessary: a documented indication has to exist in the record, which is why a wellness microbiome profile is not covered no matter who sells it. Two practical details catch people out. If a lab expects Medicare to deny a test, it will ask you to sign an Advance Beneficiary Notice, which makes you liable for the cost, so read what you are signing rather than treating it as intake paperwork. And Medicare Advantage plans apply the same medical-necessity standard but can add prior authorization and in-network lab requirements that Original Medicare does not.
How do you get a gut health test on the NHS?
You start with a GP appointment, and the GP orders the first tier directly. Typical first-line NHS testing is a full blood count, ferritin, CRP, celiac serology and faecal calprotectin, with a FIT test used to help decide who needs urgent referral. If calprotectin is raised, if FIT is positive, or if you have a red-flag feature such as rectal bleeding or unintentional weight loss, the GP refers you to gastroenterology, and the referral route and timeframe follow NICE guidance. Consumer microbiome kits are not part of any NHS pathway.
Is a GI-MAP test legitimate?
GI-MAP is a real laboratory test run by a CLIA-certified lab using quantitative PCR on a stool sample, so the measurement itself is a genuine laboratory procedure. The disagreement is about interpretation, not chemistry. Some of what it reports overlaps with mainstream testing, including calprotectin, pancreatic elastase and recognized pathogens. The rest, including reference ranges for commensal bacteria abundance and the dysbiosis frameworks built on them, is proprietary and does not appear in gastroenterology society guidance. A finding on a GI-MAP that would change management is usually one a conventional test could also have found.
What does a zonulin test show?
A zonulin result is sold as a measure of intestinal permeability, and no gastroenterology guideline currently uses it to make a decision. If permeability is genuinely your concern, note what researchers use instead: the established research method is a sugar-absorption test, where you drink two sugars such as lactulose and mannitol and the lab measures how much of each appears in urine. That has been used in studies of celiac disease and inflammatory bowel disease for decades, and it is still a research tool rather than a routine clinical one. The more useful move for most people is to test for the conditions that actually cause a permeable barrier, celiac disease and inflammatory bowel disease among them, since those have validated tests and defined treatments.
Related
- Are gut health tests accurate?: what consumer sequencing can and cannot resolve
- Best gut health test: matching a product to your actual question
- Gut health tests: the hub covering every test category
- Doctor-led options: programs that pair testing with physician review
- hs-CRP: the systemic inflammation marker ordered alongside gut work